[go: up one dir, main page]

GB202218958D0 - New pharmaceutical composition - Google Patents

New pharmaceutical composition

Info

Publication number
GB202218958D0
GB202218958D0 GBGB2218958.3A GB202218958A GB202218958D0 GB 202218958 D0 GB202218958 D0 GB 202218958D0 GB 202218958 A GB202218958 A GB 202218958A GB 202218958 D0 GB202218958 D0 GB 202218958D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
new pharmaceutical
new
composition
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2218958.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanexa AB
Original Assignee
Nanexa AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanexa AB filed Critical Nanexa AB
Priority to GBGB2218958.3A priority Critical patent/GB202218958D0/en
Publication of GB202218958D0 publication Critical patent/GB202218958D0/en
Priority to PCT/GB2023/053231 priority patent/WO2024127018A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5115Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2218958.3A 2022-12-15 2022-12-15 New pharmaceutical composition Ceased GB202218958D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2218958.3A GB202218958D0 (en) 2022-12-15 2022-12-15 New pharmaceutical composition
PCT/GB2023/053231 WO2024127018A1 (en) 2022-12-15 2023-12-14 New injectable suspension of coated particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2218958.3A GB202218958D0 (en) 2022-12-15 2022-12-15 New pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB202218958D0 true GB202218958D0 (en) 2023-02-01

Family

ID=85035717

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2218958.3A Ceased GB202218958D0 (en) 2022-12-15 2022-12-15 New pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB202218958D0 (en)
WO (1) WO2024127018A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080895A1 (en) 2005-01-20 2006-08-03 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
ES2922465T3 (en) 2013-05-24 2022-09-15 Nanexa Ab Preparation method of solid nanoparticles with an inorganic coating and use thereof
CA3163510A1 (en) * 2019-12-06 2021-06-10 Nanexa Ab New composition
GB202005593D0 (en) 2020-04-17 2020-06-03 Nanexa Ab New composition

Also Published As

Publication number Publication date
WO2024127018A1 (en) 2024-06-20

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
IL304290A (en) Pharmaceutical composition
IL314046A (en) Ribociclib pharmaceutical compositions
GB202208464D0 (en) Pharmaceutical composition
GB202104224D0 (en) Pharmaceutical composition
GB202018068D0 (en) Pharmaceutical composition
GB202010340D0 (en) Pharmaceutical composition
GB202218958D0 (en) New pharmaceutical composition
GB202218929D0 (en) New pharmaceutical composition
GB202213306D0 (en) New pharmaceutical composition
GB202208144D0 (en) New pharmaceutical composition
GB202316245D0 (en) Rapamycin-containing pharmaceutical composition
GB202117005D0 (en) New pharmaceutical composition
GB202117007D0 (en) New pharmaceutical composition
GB202117015D0 (en) New pharmaceutical composition
GB202217146D0 (en) New pharmaceutical compositions
GB202217150D0 (en) New pharmaceutical compositions
GB202018901D0 (en) New pharmaceutical composition
GB202009905D0 (en) New pharmaceutical composition
GB202007306D0 (en) New pharmaceutical composition
GB202007328D0 (en) New pharmaceutical composition
IL324773A (en) Pharmaceutical compositions
IL320961A (en) Milvexian pharmaceutical compositions
GB202109271D0 (en) Pharmaceutical composition
GB202108387D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)